Clinical Trial

Cervical Myelopathy in Hip Fracture Patients

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 28, 2026 (before its estimated July 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Recent evidence has demonstrated a high rate of undiagnosed cervical myelopathy in patients presenting with hip fractures from a ground level fall. Identification and treatment of cervical myelopathy can help prevent falls and future fragility fractures. The purpose of this study is to screen ground level fall hip fracture patients for cervical myelopathy using a history, physical exam, and then offer an MRI if indicated.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-03-18; most recent amendment 2026-05-26.
Status change: Not Yet Recruiting → Recruiting 2025-10-30
Trial Details
NCT Number NCT06893406
Lead Sponsor Indiana University
Conditions Cervical Myelopathy, Hip Fractures
Enrollment 75 participants
Start Date 2025-05-01
Primary Completion 2026-07-30 (estimated)
Study Completion 2026-07-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-28